Technion chemists develop molecule designed to lower cholesterol

Researchers at Haifa’s Technion-Israel Institute of Technology have developed a new molecule to reduce dangerous fat in blood.

September 9, 2013 02:57
1 minute read.
The site was used for many years as government buildings and army space.

New technion 521. (photo credit: Courtesy)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

For patients with high blood cholesterol who do not respond to statin drugs, researchers at Haifa’s Technion-Israel Institute of Technology have developed a new chemical molecule that helps reduce dangerous fat in the blood.

The molecule, an antioxidant known as 1- FE, fights heart disease on two fronts. Not only does it lower cholesterol, but it also eliminates oxygen free radicals that cause organs and tissues to age. The researchers maintain that this compound could be a promising alternative to statins, the most prescribed cholesterol- lowering drug in the world.

Be the first to know - Join our Facebook page.

High cholesterol and excess free radicals pose major risk factors for developing cardiovascular disease (CVD). Healthful lifestyles and low cholesterol help prevent CVD, but many people still fail to maintain optimum levels of cholesterol in the blood. Most cholesterol does not come from food; rather, it is produced by the body.

Statins reduce cholesterol levels by acting as competitive inhibitors of 3-hydroxy-3-methylglutaryl- CoA (HMG-CoA) reductase, an enzyme that causes the chemical reaction of cholesterol biosynthesis. Some people do not respond to statins or suffer from upsetting side effects.

Dr. Adi Haber, Prof. Zeev Gross and colleagues belonging to the Technion chemistry faculty have proposed an alternative to statins in RSC, a journal published by the Royal Society of Chemistry. The alternative molecule works completely differently than statins, as they have a completely different structure and are catalytic oxidation inhibitors.

These scientists plan to study the effects of 1-Fe in diabetes and other diseases connected to cholesterol.

Prof. Bato Korac, who studies oxidation-regulation mechanisms in health and disease at the University of Belgrade in Serbia, said he recognized the advantages of the new complex.

All these processes, he said, open up new perspectives on the treatment of diseases characterized by high levels of blood cholesterol.

Related Content

August 31, 2014
Weizmann scientists bring nature back to artificially selected lab mice